Medicines
The new pharmacy funding deal has revealed incoming changes to the medicines margin, including plans for an “early entry” Category M process.
The government has announced that it is “going with” hub-and-spoke model one, following “overwhelmingly positive” responses to its consultation on the reforms.
A Northern Irish fitness-to-practise (FtP) committee has suspended a pharmacist for six months after he “unlawfully obtained” prescription-only medicines (POMs) from his workplace “without a valid prescription”.
A health and social care think tank has revealed that the “elevated and troubling level” of medicine shortages in the UK can be blamed on Brexit.
A new study has revealed that the use of GLP-1RAs such as semaglutide are “not associated” with an increased risk of suicidality among patients with type 2 diabetes.
Consultation numbers for a pharmacy service provider’s weight management service have grown “exponentially” in the last year, C+D has learned.
Two pharmacists have been struck off the register in separate hearings after being convicted of supplying controlled Class C drugs for their own “financial gain”.
Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.
Alliance Healthcare has revealed “plans to close” two Midlands service centres and proposed cuts at another, putting hundreds of jobs at risk.
The Danish drugmaker has launched a “direct-to-patient” pharmacy, offering "all dose strengths of Wegovy at a reduced cost”.